ArthritisPhase 2/3NCT00146393
Health Benefits of an Exercise Program for Adults With Arthritis
A Phase 2/3 study testing People with Arthritis Can Exercise program in people with Arthritis and Osteoarthritis, run by Centers for Disease Control and Prevention.
Trial summary
The primary goal of this study is to assess the effect of People with Arthritis Can Exercise (PACE), a community-based group recreational exercise program, on key arthritis-related health outcomes among adults with arthritis. Read more about this study
- Who is it for?
- Ages 18 years and older
- Conditions the study is for
- Arthritis, Osteoarthritis, Rheumatoid Arthritis
- What is being tested?
- People with Arthritis Can Exercise program
- Type of treatment
- Lifestyle or therapy programme
- How many people
- 347 participants
- Where
- No sites listed yet
- Study dates
- Jul 2003to Jun 2004
- Phase
- Phase 2/3
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- No healthy volunteers
- Adult, Older adult
Who may be able to join
- Adults over age 18
- Have some form of arthritis (examples: osteoarthritis, rheumatoid arthritis, lupus, fibromyalgia, gout, etc.)
- Be able to move independently without assistance
- Currently exercising less than 3 times per week
Who cannot join
- Inability to walk without assistance
- Severe health condition where exercise is contraindicated
About this study
Official title: Evaluation of People With Arthritis Can Exercise
The primary goal of this study is to assess the effect of People with Arthritis Can Exercise (PACE), a community-based group recreational exercise program, on key arthritis-related health outcomes among adults with arthritis.
Read the detailed description
Self-management is very important in chronic diseases, and promoting physical activity is a key public health strategy for arthritis management. Although several exercise programs such as People with Arthritis Can Exercise (PACE) have been created to implement this strategy, none have sufficient scientific evidence supporting their effectiveness to promote the programs through public health avenues.
The primary goal of this study is to assess the effect of PACE(People with Arthritis Can Exercise), a community-based group recreational exercise program, on key arthritis-related health outcomes. The primary goal of the study will be accomplished through an eight week randomized controlled trial conducted with 480 participants residing in eight urban or rural communities in North Carolina. This project is designed to evaluate the effectiveness of the program in changing arthritis-related health outcomes such as pain, function and physical activity levels. The project will compare the eight week PACE program to a control group.
The specific objectives are as follows: (The aims have not been modified.)
- To further review the PACE conceptual framework and materials in order to develop a standardized PACE protocol to be delivered in the study as well as to refine study measures.
- To work closely with the Carolinas AF Chapter to develop collaborative relationships with local health departments and key contacts in communities identified for PACE implementation.
- To recruit 480 individuals to participate in a randomized controlled trial of PACE in eight communities and to implement the PACE program.
- To compare changes in key arthritis-related health outcomes between PACE participants and controls over eight weeks (PACE course time frame).
- To determine longer-term benefits of the PACE intervention by examining key arthritis-related health outcomes 3 and 6 months post completion of the intervention.
- To conduct qualitative research among PACE completers and non-completers to determine motivators and barriers to success, as well as to determine the acceptability and suitability of the program.
- To formulate recommendations or modifications for implementation of the PACE program.
- Conditions
- Arthritis, Osteoarthritis, Rheumatoid Arthritis
- Being tested
- People with Arthritis Can Exercise program
- Keywords
- exercise, physical activity, physical conditioning, pain, physical function
- Medical subject headings
- Arthritis, Osteoarthritis, Arthritis, Rheumatoid, Motor Activity, Pain
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
People with Arthritis Can Exercise programBehavioural
What is being measured
The primary outcome is the main question the study is designed to answer.
Visual Analog Scale pain level at baseline, 2, 3 and 6 months
Self-reported physical function (Health Assessment Questionnaire) at baseline, and 2, 3 and 6 months
Measured function (6 minute walk, 360 deg turn, walking speed and timed chair stands, 10 lb lift) at baseline and 2 months
Physical activity level (Physical Activity Scale for the Elderly : PASE) at baseline, 2, 3 and 6 months
Secondary outcomes (8)
Visual analog scale fatigue
Visual analog scale stiffness
Rheumatoid Arthritis Self-efficacy Scale (RASE)
Center for Epidemiologic Studies Depression Scale (CES-D)
Outcomes Expectations for Exercise (OEE)
COnfidence Self-efficacy (CSE)
Rheumatology Attitudes Index (RAI)
Tampa Scale for Kinesiophobia (TSK)
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted7 Sep 2005 (estimated)
- Study startJul 2003
- Study completionJun 2004
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (2)Papers the sponsor has linked to this study.
- Other trials for ArthritisStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase 2/3
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Single group
- Masking
- None (open label)
- Enrolment
- 347 participants
Sponsor and investigators
- Lead sponsor
- Centers for Disease Control and Prevention
- Sponsor type
- US federal agency
- Collaborators
- University of North Carolina
- Investigators
- Jennifer M Hootman, PhD, Study chair, Centers for Disease Control and PreventionLeigh Callahan, PhD, Principal investigator, University of North Carolina, Chapel Hill
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT00146393
- Sponsor's protocol ID
- CDC-NCCDPHP-0275
- Other IDs
- CDC-PEP-MM0275
- Status last verified
- Sep 2005
- First submitted
- 2 Sep 2005
- Last updated
- 9 Dec 2005
- Results posted
- No
Publications
Schoster B, Callahan LF, Meier A, Mielenz T, DiMartino L. The People with Arthritis Can Exercise (PACE) program: a qualitative evaluation of participant satisfaction. Prev Chronic Dis. 2005 Jul;2(3):A11. Epub 2005 Jun 15.
PubMed 15963313Callahan LF, Mielenz T, Freburger J, Shreffler J, Hootman J, Brady T, Buysse K, Schwartz T. A randomized controlled trial of the people with arthritis can exercise program: symptoms, function, physical activity, and psychosocial outcomes. Arthritis Rheum. 2008 Jan 15;59(1):92-101. doi: 10.1002/art.23239.
PubMed 18163409
Study at a glance
From the registry record, last updated by the sponsor on 9 Dec 2005. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Evaluation of People With Arthritis Can Exercise
- ClinicalTrials.gov ID
- NCT00146393
- Acronym / sponsor ID
- CDC-NCCDPHP-0275
- Conditions
- Arthritis, Osteoarthritis, Rheumatoid Arthritis
- Keywords
- exercise, physical activity, physical conditioning, pain, physical function
- Phase
- Phase 2/3
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 347 participants
- Lead sponsor
- Centers for Disease Control and PreventionUS federal agency
- Collaborators
- University of North Carolina
- Study start
- Jul 2003
- Study completion
- Jun 2004
- First posted
- 7 Sep 2005 (estimated)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The primary goal of this study is to assess the effect of People with Arthritis Can Exercise (PACE), a community-based group recreational exercise program, on key arthritis-related health outcomes among adults with arthritis.
Detailed description
Self-management is very important in chronic diseases, and promoting physical activity is a key public health strategy for arthritis management. Although several exercise programs such as People with Arthritis Can Exercise (PACE) have been created to implement this strategy, none have sufficient scientific evidence supporting their effectiveness to promote the programs through public health avenues.
The primary goal of this study is to assess the effect of PACE(People with Arthritis Can Exercise), a community-based group recreational exercise program, on key arthritis-related health outcomes. The primary goal of the study will be accomplished through an eight week randomized controlled trial conducted with 480 participants residing in eight urban or rural communities in North Carolina. This project is designed to evaluate the effectiveness of the program in changing arthritis-related health outcomes such as pain, function and physical activity levels. The project will compare the eight week PACE program to a control group.
The specific objectives are as follows: (The aims have not been modified.)
- To further review the PACE conceptual framework and materials in order to develop a standardized PACE protocol to be delivered in the study as well as to refine study measures.
- To work closely with the Carolinas AF Chapter to develop collaborative relationships with local health departments and key contacts in communities identified for PACE implementation.
- To recruit 480 individuals to participate in a randomized controlled trial of PACE in eight communities and to implement the PACE program.
- To compare changes in key arthritis-related health outcomes between PACE participants and controls over eight weeks (PACE course time frame).
- To determine longer-term benefits of the PACE intervention by examining key arthritis-related health outcomes 3 and 6 months post completion of the intervention.
- To conduct qualitative research among PACE completers and non-completers to determine motivators and barriers to success, as well as to determine the acceptability and suitability of the program.
- To formulate recommendations or modifications for implementation of the PACE program.
Study design
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Single group
- Masking
- None (open label)
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (4 listed)
- Adults over age 18
- Have some form of arthritis (examples: osteoarthritis, rheumatoid arthritis, lupus, fibromyalgia, gout, etc.)
- Be able to move independently without assistance
- Currently exercising less than 3 times per week
Key exclusion criteria (2 listed)
- Inability to walk without assistance
- Severe health condition where exercise is contraindicated
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| People with Arthritis Can Exercise program | Behavioural | – |
Primary outcome
Visual Analog Scale pain level at baseline, 2, 3 and 6 months
Self-reported physical function (Health Assessment Questionnaire) at baseline, and 2, 3 and 6 months
Measured function (6 minute walk, 360 deg turn, walking speed and timed chair stands, 10 lb lift) at baseline and 2 months
Physical activity level (Physical Activity Scale for the Elderly : PASE) at baseline, 2, 3 and 6 months
8 secondary outcomes
Visual analog scale fatigue
Visual analog scale stiffness
Rheumatoid Arthritis Self-efficacy Scale (RASE)
Center for Epidemiologic Studies Depression Scale (CES-D)
Outcomes Expectations for Exercise (OEE)
COnfidence Self-efficacy (CSE)
Rheumatology Attitudes Index (RAI)
Tampa Scale for Kinesiophobia (TSK)
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 9 Dec 2005.
- Results publication: PubMed 15963313Schoster B, Callahan LF, Meier A, Mielenz T, DiMartino L. The People with Arthritis Can Exercise (PACE) program: a qualitative evaluation of participant satisfaction. Prev Chronic Dis. 2005 Jul;2(3):A11. Epub 2005 Jun 15.
- Derived from this study: PubMed 18163409Callahan LF, Mielenz T, Freburger J, Shreffler J, Hootman J, Brady T, Buysse K, Schwartz T. A randomized controlled trial of the people with arthritis can exercise program: symptoms, function, physical activity, and psychosocial outcomes. Arthritis Rheum. 2008 Jan 15;59(1):92-101. doi: 10.1002/art.23239.
Related trials for Arthritis
RecruitingPhase 1
A Study to Learn if Bimekizumab Given in Different Ways is Safe and Moves Similarly Throughout the Body Over Time in Adults
Psoriatic Arthritis, Axial Spondyloarthritis
Recruiting
Efficacy of a Self-Management Smartphone App to Improve Safety Skills in Patients With Inflammatory Arthritis
Rhumatoid Arthisis, Spondyloarthritis (SA)
RecruitingPhase 2
Study of PTC844 in Participants With Active Rheumatoid Arthritis
Rheumatoid Arthritis
Not yet recruitingPhase 1
An Ascending Dose Study of DKB903 in Participants With Rheumatoid Arthritis (RA) and Participants With Systemic Lupus Erythematosus (SLE)
Rheumatoid Arthritis and Systemic Lupus Erythematosus
Not yet recruitingPhase 2
Extension Study of Safety and Tolerability of DDY391 in Participants With Moderate to Severe Psoriatic Arthritis (CDDY391A12201-extension)
Moderate to Severe Psoriatic Arthritis
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Jennifer M Hootman, PhD study chair
Centers for Disease Control and Prevention
Leigh Callahan, PhD principal investigator
University of North Carolina, Chapel Hill
Questions about this trial
What is this clinical trial studying?
A Phase 2/3 study testing People with Arthritis Can Exercise program in people with Arthritis and Osteoarthritis, run by Centers for Disease Control and Prevention.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 4 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 9 Dec 2005. Status can change between updates, so confirm with the study contact before making plans.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
What does this combined phase mean?
Phase 2 studies give the treatment to a larger group to see whether it has the intended effect and to keep checking safety.
Phase 3 studies compare the treatment with the current standard treatment or a placebo in a large group, to confirm how well it works and watch for side effects.
Not every study follows the same path, and some studies (observational studies, device studies) have no phase.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Visual Analog Scale pain level at baseline, 2, 3 and 6 months. The study lists 4 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT00146393, which also lists 2 linked publications.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 9 Dec 2005.